Key Points
- Ainos director Ting-Chuan Lee sold 109,988 shares on Tuesday at an average price of $1.90, for proceeds of about $208,977. After the sale, Lee still owned 807,417 shares, a decrease of 11.99% in ownership.
- Ainos stock fell 19.0% and was trading at $2.56, with a market cap of $21.81 million. The company’s shares have ranged from $1.26 to $4.50 over the past 52 weeks.
- Sentiment remains weak after Ainos reported a quarterly loss of $0.41 per share, and Weiss Ratings lowered its view from “sell (e+)” to “sell (d-).” MarketBeat says the stock’s average analyst rating is still “Sell.”
Ainos, Inc. (NASDAQ:AIMD - Get Free Report) Director Chun-Jung Tsai sold 27,718 shares of the company's stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.87, for a total transaction of $51,832.66. Following the sale, the director directly owned 658,199 shares of the company's stock, valued at approximately $1,230,832.13. This represents a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Chun-Jung Tsai also recently made the following trade(s):
- On Friday, May 22nd, Chun-Jung Tsai sold 1,082 shares of Ainos stock. The stock was sold at an average price of $1.55, for a total transaction of $1,677.10.
Ainos Price Performance
NASDAQ AIMD opened at $2.56 on Thursday. The company has a current ratio of 0.55, a quick ratio of 0.50 and a debt-to-equity ratio of 1.58. The company has a fifty day simple moving average of $1.67 and a 200 day simple moving average of $1.83. The company has a market cap of $21.81 million, a P/E ratio of -0.89 and a beta of 2.29. Ainos, Inc. has a 1 year low of $1.26 and a 1 year high of $4.50.
Ainos (NASDAQ:AIMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.
Hedge Funds Weigh In On Ainos
Hedge funds have recently made changes to their positions in the business. Mariner LLC acquired a new position in shares of Ainos in the 4th quarter valued at $37,000. Two Sigma Investments LP acquired a new position in shares of Ainos in the 3rd quarter valued at $80,000. DRW Securities LLC raised its stake in shares of Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company's stock valued at $109,000 after buying an additional 48,439 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company's stock valued at $109,000 after buying an additional 7,700 shares in the last quarter.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised shares of Ainos from a "sell (e+)" rating to a "sell (d-)" rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Ainos currently has a consensus rating of "Sell".
Check Out Our Latest Stock Analysis on AIMD
Ainos Company Profile
(
Get Free Report)
Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company's proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.
The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
